Abiopharma

Change in holdings of interested parties/officers

Updates regarding developments in the company’s business in view of examining the possibility of a capital issuance by way of a public offering

Examining the possibility of issuing BONDS Series 13 and/or BONDS Series 14, intention to hold a classified investors auction on 1.6.26

Examining the possibility of issuing shares, intention to hold a tender for classified investors on 1.6.26

Commercial papers interest 5 for the period 5.6.25-4.6.26 is 4.35301% - correction of the record date

Quarter 1 report for 2026

FORM N-2-POST-EFFECTIVE AMENDMENT NO. 13

FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP-Barry John F

Register of shareholders, changes and share capital status – exercise of warrants (Series 4)

Dormant shares - change in the number of shares